mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.09 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.09 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |